Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2

Cancer Research

Volumn 57, Issue 6, 1997, Pages 1081-1085

  Mestre, Juan R ^b   Subbaramaiah, Kotha ^a   Sacks, Peter G ^b   Schantz, Stimson P ^b   Tanabe, Tadashi ^c   Inoue, Hiroyasu ^c   Dannenberg, Andrew J ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; ISOTRETINOIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PROSTAGLANDIN E2; RETINOIC ACID; RETINOID; RETINOL ACETATE;

ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME INHIBITION; EPITHELIUM CELL; GENE ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS;

ANTICARCINOGENIC AGENTS; BIOTRANSFORMATION; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME INDUCTION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; ISOTRETINOIN; MEMBRANE PROTEINS; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PEROXIDASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR CELLS, CULTURED; VITAMIN A;

EID: 0030890993     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Eling, T. E., Thompson, D. C., Foureman, G. L., Curtis, J. F., and Hughes, M. F. Prostaglandin H synthase and xenobiotic oxidation. Annu. Rev. Pharmacol. Toxicol., 30: 1-45, 1990.
2. Eling, T. E., and Curtis, J. F. Xenobiotic metabolism by prostaglandin H synthase. Pharmacol. Ther., 3: 261-273, 1992.
3. Marnett, L. J. Aspirin and potential role of prostaglandins in colon cancer. Cancer Res., 52: 5575-5589, 1992.
4. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
5. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B. S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55: 1464-1472, 1995.
6. McCormick, D. L., and Moon, R. C. Inhibition of mammary carcinogenesis by flurbi-profen, a non-steroidal antiinflammatory agent. Br. J. Cancer, 48: 859-861, 1983.
7. Perkins, T. M., and Shklar, G. Delay in hamster buccal pouch carcinogenesis by aspirin and indomethacin. Oral Surg., 53: 170-178, 1982.
8. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantodosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, R. C., and Offerhaus, G. J. A. Treatment of colonic rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
9. Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., and Herschman, H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 266: 12866-12872, 1991.
10. O'Banion, M. K., Sadowsky, H. B., Winn, V., and Young, D. A. A serum and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J. Biol. Chem., 266: 23261-23267, 1991.
11. Lee, S. H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D., and Hwang, D. Selective expression of mitogen-inducible cyclooxy-genases in macrophages stimulated with lipopolysaccharide. J. Biol. Chem., 267: 25934-25938, 1992.
12. DuBois, R. N., Awad, J., Morrow, J., Roberts, L. J., and Bishop, P. R. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Invest., 93: 493-498, 1994.
13. Rimarachin, J. A., Jacobson, J. A., Szabo, P., Maclouf, J., Creminon, C., and Weksler, B. B. Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arterioscler. Thromb., 14: 1021-1031, 1994.
14. Xie, W., Fletcher, B. S., Andersen, R. D., and Herschman, H. R. v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element. Mol. Cell. Biol., 14: 6531-6539, 1994.
15. Moon, R. C., McCormick, D. L., and Mehta, R. G. Inhibition of carcinogenesis by retinoids. Cancer Res., 43: 2469s-2475s, 1983.
16. Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., Toth, B. B., Kramer, A., Dimery, I. W., Skipper, P., and Strong, S. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med., 315: 1501-1505, 1986.
17. Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., Dimery, I. W., Brown, B. W., and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
18. Zhang, L-X., Mills, K. J., Dawson, M. I., Collins, S. J., and Jetten, A. M. Evidence for the involvement of retinoic acid receptor RARα-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J. Biol. Chem., 270: 6022-6029, 1995.
19. Oridate, N., Lotan, D., Xu, X-C, Hong, W. K., and Lotan, R. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res., 2: 855-863, 1996.
20. Jang, X. L., Dillehay, D. L., Everson, M. P., Tilden, A. B., and Lamon, E. W. Potentiation of IL-2-induced T-cell proliferation by retinoids. Int. J. Immunopharmacol., 14: 195-204, 1992.
21. Schule, R., Rangarajan, P., Yang, N., Kliewer, S., Ransone, L. J., Bolado, J., Verma, I. M., and Evans, R. M. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc. Natl. Acad. Sci. USA, 88: 6092-6096, 1991.
22. Salbert, G., Fanjul, A., Piedrafita, F. J., Lu, X. P., Kim, S- J., Tran, P., and Pfahl, M. Retinoic acid receptors and retinoid X receptor-α downregulate the transforming growth factor-β1 promoter by antagonizing AP-1 activity. Mol. Endocrinol., 7: 1347-1356, 1993.
23. Lafyatis, R., Kim, S-J., Angel, P., Roberts, A. B., Sporn, M. B., Karin, M., and Wilder, R. L. Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5′ activator protein-1-binding site. Mol. Endocrinol., 4: 973-980, 1990.
24. Xie, W., and Herschman, H. R. v-src induces prostaglandin synthase 2 gene expression by activation of c-Jun N-terminal kinase and the c-Jun transcription factor. J. Biol. Chem., 270: 27622-27628, 1995.
25. Sacks, P. G., Parnes, S. M., Gallick, G. E., Mansouri, Z., Lichtner, R., Satya-Prakash, K. L., Pathak, S., and Parsons, D. F. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res., 48: 2858-2866, 1988.
26. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randell, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
27. Weksler, B. B. Heparin and acidic fibroblast growth factor interact to decrease prostacyclin synthesis in human endothelial cells by affecting both prostaglandin H synthase and prostacyclin synthase. J. Cell. Physiol., 142: 514-522, 1990.
28. Laemmli, U. K. Cleavage of structural proteins during the assembly of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
29. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.
30. Habib, A., Creminon, C., Frobert, Y., Grassi, J., Pradelles, P., and Maclouf, J. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of cyclooxygenase-2. J. Biol. Chem., 268: 23448-23454, 1993.
31. Yang, E. K., Radominska, A., Winder, B. S., and Dannenberg, A. J. Dietary lipids coinduce xenobiotic metabolizing enzymes in rat liver. Biochim. Biophys. Acta, 1168: 52-58, 1993.
32. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
33. Inoue, H., Nanayama, T., Hara, S., Yokoyama, C., and Tanabe, T. The cyclic AMP response element plays an essential role in the expression of the human prostaglandin-endoperoxide synthase 2 gene in differentiated U937 cells. FEBS Lett., 350: 51-54, 1994.
34. Subbaramaiah, K., Telang N., Ramonetti, J. T., Araki, R., DeVito, B., Weksler, B. B., and Dannenberg, A. J. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res., 56: 4424-4429, 1996.
35. Kutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., and Prescott, S. M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA, 93: 4816-4820, 1996.
36. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995.
37. Kargman, S. L., O'Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A., and Jothy, S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55: 2556-2559, 1995.
38. Wyatt, G. P., Joshi, I., Sharma, S., Kelloff, G. J., and Steele, V. E. Efficacy of retinoids as inhibitors of carcinogen-DNA binding and free radical scavengers. Proc. Am. Assoc. Cancer Res., 37: 1830, 1996.
39. Lu, X., Xie, W., Reed, D., Bradshaw, W. S., and Simmons, D. L. Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenase in chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 7961-7965, 1995.
40. Weitzman, S. A., and Gordon, L. I. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood, 76: 655-663, 1990.
41. Brinckerhoff, C. E., Coffey, J. W., and Sullivan, A. C. Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis-retinoic acid. Science (Washington DC), 221: 756-758, 1983.
42. Zou, C-P., Clifford, J. L., Xu, X-C., Sacks, P. G. Chambon, P., Hong, W. K., and Lotan, R. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Cancer Res., 54: 5479-5487, 1994.
43. Inoue, H., Yokoyama, C., Hara, S., Tone, Y., Tanabe, T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. J. Biol. Chem., 270: 24965-24971, 1995.
44. Nagpal, S., Athanikar, J., and Chandraratna, R. A. S. Separation of transactivation and API antagonism functions of retinoic acid receptor α. J. Biol. Chem., 270: 923-927, 1995.
45. Fanjul, A., Dawson, M. I., Hobbs, P. D., Jong, L., Cameron, J. F., Harlev, E., Graupner, G., Lu, X-P., and Pfahl, M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature (Lond.), 372: 107-111, 1994.